Asthma Clinical Trials in Philadelphia, PA

15 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids	Phase 2	AstraZeneca	<1 mi
Investigating Dupilumab's Effect in Asthma by Genotype	Phase 4	Boston Children's Hospital	<1 mi
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma	Phase 2	Sanofi	<1 mi
SMART Implementation-Effectiveness Trial 1	N/A	Children's Hospital of Philadelphia	<1 mi
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations	Phase 3	Teva Branded Pharmaceutical Products R&D LLC	<1 mi
SMART Implementation-Effectiveness Trial 2	N/A	Children's Hospital of Philadelphia	<1 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma	Phase 3	Teva Branded Pharmaceutical Products R&D, Inc.	<1 mi
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma	Phase 2	Incyte Corporation	<1 mi
A Study to Evaluate Solriktug in Adult Participants With Asthma	Phase 2	Uniquity One (UNI)	<1 mi
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma	Phase 4	Sanofi	<1 mi
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma	Phase 4	Regeneron Pharmaceuticals	7 mi
GRANITE: Airsupra Effectiveness in the Real World	—	AstraZeneca	25 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	25 mi
Tezspire Cardiac Events PASS	—	AstraZeneca	25 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma	Phase 3	AstraZeneca	25 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.